{"paper_id": "65e058593f16a20803e316d83520aed17b8319b9", "metadata": {"title": "Wiener klinische Wochenschrift The Central European Journal of Medicine Pneumonia in patients with novel infl uenza A (H1N1) virus in Southeastern Turkey Pneumonie bei Patienten mit einer Infektion mit dem neuen Infl uenza A (H1N1) Virus in der S\u00fcdost-T\u00fcrkei", "authors": [{"first": "Tacettin", "middle": [], "last": "\u00d6rnek", "suffix": "", "affiliation": {"laboratory": "", "institution": "Zonguldak Karaelmas University Medical Faculty", "location": {"settlement": "Zonguldak", "country": "Turkey"}}, "email": ""}, {"first": "Funda", "middle": [], "last": "Demirta\u015f Yal\u00e7\u0131n", "suffix": "", "affiliation": {"laboratory": "", "institution": "\u015eanl\u0131urfa Education and Research Hospital", "location": {"settlement": "\u015eanl\u0131urfa", "country": "Turkey"}}, "email": ""}, {"first": "Selami", "middle": [], "last": "Ekin", "suffix": "", "affiliation": {"laboratory": "", "institution": "\u015eanl\u0131urfa Education and Research Hospital", "location": {"settlement": "\u015eanl\u0131urfa", "country": "Turkey"}}, "email": ""}, {"first": "\u015eaban", "middle": [], "last": "Yal\u00e7\u0131n", "suffix": "", "affiliation": {"laboratory": "", "institution": "Harran University Medical Faculty", "location": {"settlement": "\u015eanl\u0131urfa", "country": "Turkey"}}, "email": ""}, {"first": "M\u00fccahit", "middle": [], "last": "Yemi\u015fen", "suffix": "", "affiliation": {"laboratory": "", "institution": "\u015eanl\u0131urfa Bal\u0131kl\u0131g\u00f6l State Hospital", "location": {"settlement": "\u015eanl\u0131urfa", "country": "Turkey"}}, "email": ""}]}, "abstract": [{"text": "Zusammenfassung. Ziel dieser Studie war es, die klinischen Charakteristika, sowie die R\u00f6ntgen-und Laborbefunde von hospitalisierten Patienten mit einer neuen, laborm\u00e4\u00dfig gesicherten, Infektion mit dem Schweine-Grippe Infl uenza A Virus (S-OIV) mit Pneumonie zu beschreiben.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Es wurden 56 zwischen Oktober und Dezember 2009 wegen einer Pneumonie station\u00e4r aufgenommene Patienten, die auf S-OIV getestet worden waren, retrospektiv ausgewertet. 33 dieser Patienten hatten einen positiven Befund. Sie wurden mit den 23 Patienten mit negativem Befund verglichen.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Die Mortalit\u00e4t der Patienten mit positivem Befund lag bei 24,2 %. Von den 33 Patienten hatten 42,4 % zumindest eine zugrunde liegende Erkrankung und 4 (12 %) Patientinen waren schwanger oder post partum. 14 der Patienten mit S-OIV Infektion wurden in einer Intensivstation behandelt. Das h\u00e4ufi gste Symptom war Atemnot. Die mittlere Spitzen -K\u00f6rpertemperatur w\u00e4hrend des station\u00e4ren Aufenthaltes war in dieser Gruppe mit 39,42 \u00b1 0,70 Grad Celsius h\u00f6her als in der Gruppe mit negativem S-OIV Befund (38,51 \u00b1 1,05) (p = 0,001). Auch die Th rombozytopenie sowie der Anstieg der Creatin-Kinase und der Laktatdehydrogenase waren statistisch signifi kant ausgepr\u00e4gter. Bei den Patienten mit S-OIV Infektion war eine bilaterale Infi ltration im Vergleich h\u00e4ufi ger.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Obwohl sich manche klinischen Daten und R\u00f6ntgensowie Laborbefunde der Patienten mit S-OIV Infektion von den bei S-OIV negativen Patienten erhobenen Befunden signifi kant unterschieden, sollten unseres Er-achtens alle Patienten mit einer Pneumonie w\u00e4hrend einer Pandemie auf Infl uenza A getestet werden.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Th e objective of this study was to describe the clinical characteristics and the radiological and laboratory fi ndings of the hospitalised patients who had novel, laboratory-confi rmed, swine-origin infl uenza A virus (S-OIV) infection with pneumonia.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Between October and December 2009, 56 patients hospitalised for pneumonia who were tested for S-OIV infection were retrospectively evaluated. Th irty-three patients had positive S-OIV infections. In addition, 23 of the 56 patients who had negative test results for S-OIV infection were compared with the positive group.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Th e mortality rate amongst the patients with S-OIV infection was 24.2%. Of the 33 patients, 42.4% had at least one underlying medical condition and 4 (12%) patients were pregnant or postpartum. Fourteen patients (42.4%) with S-OIV infection were followed up in an intensive care unit. Th e most common symptom was dyspnea. Th e mean peak body temperature during hospital stay (39.42 \u00b1 0.70) was higher in this group than in the negative group (38.51 \u00b1 1.05) (p = 0.001). Th rombocytopenia, increased creatine kinase and elevated lactate dehydrogenase levels were statistically signifi cant. Bilateral infi ltration was more common in the patients with S-OIV infection.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Although some laboratory, radiological and clinical data show a signifi cant diff erence between the patients with S-OIV pneumonia and the negative group, each patient presenting with signs of pneumonia during pandemia should be tested for Infl uenza A.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "Swine infl uenza (H1N1) is a novel infl uenza A virus comprising a reassortment of four distinct genetic elements, swine, human, avian, and Eurasian swine genetic components, which combine to form a single infl uenza virus [1] . Th e fi rst human infections with the new swine-origin infl uenza A virus (S-OIV) were confi rmed in April 2009 in Mexico and the United States. Since then, Turkey and several other countries experienced outbreaks of respiratory illness caused by S-OIV. On 11 June 2009, WHO announced a global 2009 infl uenza pandemic [2] . On 16 May 2009, the fi rst infection by S-OIV in Turkey was reported. Outbreak spread throughout the country during the winter wave; the fi rst death due to S-OIV infection in Turkey occurred on 24 October 2009. Previous studies have reported that a prominent clinical feature of S-OIV infection is severe pneumonia [3] [4] [5] . In this report, we aim to describe the clinical characteristics and the radiological and laboratory fi ndings of patients with H1N1 virus pneumonia who lived in the southeastern region of Turkey. Attempts to defi ne specifi c clinical or laboratory parameters to distinguish S-OIV from other types of pneumonia might facilitate early suspicion of S-OIV infection.", "cite_spans": [{"start": 223, "end": 226, "text": "[1]", "ref_id": "BIBREF0"}, {"start": 548, "end": 551, "text": "[2]", "ref_id": "BIBREF1"}, {"start": 749, "end": 765, "text": "24 October 2009.", "ref_id": null}, {"start": 870, "end": 873, "text": "[3]", "ref_id": "BIBREF2"}, {"start": 874, "end": 877, "text": "[4]", "ref_id": "BIBREF3"}, {"start": 878, "end": 881, "text": "[5]", "ref_id": "BIBREF4"}], "ref_spans": [], "section": "Introduction"}, {"text": "Th is study was performed at \u015eanl\u0131urfa Education and Research Hospital, which is located in the southeastern region of Turkey. We retrospectively reviewed medical charts and radiological and laboratory fi ndings of the patients who were followed up at the hospital between 27 October 2009 and 26 December 2009. We enrolled all hospitalised patients with pneumonia for whom nasopharyngeal swab specimens were collected due to suspected S-OIV infection. We separated the patients into two groups. In the positive group, 33 patients had laboratory-confi rmed S-OIV infection. Twenty-three patients without an S-OIV infection (confi rmed by laboratory tests) were used to document the diff erences between the patients with or without S-OIV infection.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "Nasopharyngeal swab specimens were collected upon admission and kept at a temperature ranging from 4 to 8\u00b0C. Specimens were sent to a Turkish government health ministry laboratory centre called \"Refi k Saydam H\u0131fs\u0131zs\u0131hha Center Presidency\" (RSHCP). Specimens were tested using real-time reverse-transcriptasepolymerase-chain-reaction (rRT-PCR), in accordance with the guidelines provided by the WHO. At the national infl uenza centre of RSHCP, diagnosis of infl uenza and viruses-forming infl uenzalike illness was achieved using primers and probe sequence provided by the U.S. Centers for Disease Control (CDC) [6] .", "cite_spans": [{"start": 612, "end": 615, "text": "[6]", "ref_id": "BIBREF5"}], "ref_spans": [], "section": "Microbiological studies"}, {"text": "Data analysis was conducted using SPSS 11.5 statistical software. Continuous variables were summarised as means (\u00b1 SD) or medians (with interquartile ranges). A P value of less than 0.05 was considered statistically signifi cant. Mann-Whitney U-test, Chisquare test, or Fisher's exact test was used as appropriate. All values were two-sided.", "cite_spans": [], "ref_spans": [], "section": "Statistical analysis"}, {"text": "Demographic characteristics of the patients with S-OIV infection are shown in Table 1 . Th e minimum and maximum ages of the positive group were 13 and 70 years, respectively, with a median age of 30 years. Th e median age of the negative group was 34 years, with a range of 15-80 years; 57.6% of the positive group and 69.6% of the negative group had no comorbidities. In the positive group, 9 of 33 patients had pulmonary disease, such as chronic obstructive pulmonary disease (COPD) or asthma, 3 patients were pregnant, 2 patients had type 2 diabetes mellitus and 1 patient was postpartum. Other comorbidities in the positive group were Down syndrome (n = 1), hypertension (n = 1) and congestive heart failure (n = 1). Th ere were no pregnant or postpartum patients in the negative group, and 4 of 23 patients had pulmonary disease, such as chronic obstructive pulmonary disease (COPD) or asthma.", "cite_spans": [], "ref_spans": [{"start": 78, "end": 85, "text": "Table 1", "ref_id": "TABREF0"}], "section": "Results"}, {"text": "Fourteen patients (42.4%) in the positive group and 8 patients (34.8%) in the negative group were followed up in the intensive care unit (ICU). Th e duration of hospital stay (6.42 \u00b1 4.56 days) and ICU stay (6.0 \u00b1 6.0) in the positive group was lower than in the negative group (8.0 \u00b1 5.50 days, 7.37 \u00b1 7.55 days, respectively), but this difference was not statistically signifi cant (p = 0.296 and 0.810, respectively). A comparison of the symptoms between the groups during admission is shown in Table 2 . Th e most common symptom was dyspnea in the positive group. Dyspnea and sore throat were more common in the positive group (p = 0.015 and 0.039, respectively).", "cite_spans": [], "ref_spans": [{"start": 498, "end": 505, "text": "Table 2", "ref_id": "TABREF1"}], "section": "Results"}, {"text": "In auscultation, crackles were identifi ed in 63.6% (n = 21) of the positive group. 54.5% of the crackles were bilateral. Cyanosis and mental confusion were seen more frequently in the positive group (n = 11, 33.3% and n = 15, 45.5%, respectively) than in the negative group (n = 3, 13.0% and n = 7, 30.4%, respectively) but this diff erence was not statistically signifi cant (p = 0.258 and 0.120, respectively). Th e mean highest body temperature during the hospital stay of the positive group (39.42 \u00b1 0.70) was higher than that of the negative group (38.51 \u00b1 1.05) (p = 0.001). Th e frequency of mechanical ventilation (MV), Acute Respiratory Distress Syndrome (ARDS) and death was higher than in the negative group, but this diff erence was not statistically signifi cant (p = 0.496, 1 and 0.172, respectively) ( Table 3 ). Neither patients in the positive group with ARDS nor those who underwent MV survived.", "cite_spans": [], "ref_spans": [{"start": 818, "end": 825, "text": "Table 3", "ref_id": "TABREF2"}], "section": "Results"}, {"text": "A complete blood cell count was performed on all 33 patients and on the negative group. Th e results of the blood cell count and other biochemical parameters are shown in Table 4 . Th rombocytopenia, increased creatine kinase and elevated lactate dehydrogenase levels were observed in the patients with S-OIV infection (p = 0.007, 0.014 and 0.019, respectively). Th e mean value of platelet count was 202.575 \u00b1 129.600 and 283.608 \u00b1 133.290 in the positive group and negative group, respectively (p = 0.002). Th e mean value of creatine kinase and serum creatinin was higher in the positive group (337.40 \u00b1 385.14 and 0.82 \u00b1 0.31, respectively) than in the negative group (191.89 \u00b1 327.63 and 0.67 \u00b1 0.19, respectively) (p = 0.033 and 0.026, respectively).", "cite_spans": [], "ref_spans": [{"start": 171, "end": 178, "text": "Table 4", "ref_id": "TABREF3"}], "section": "Laboratory results"}, {"text": "Th e mean arterial PO 2 of the patients with S-OIV and the S-OIV negative group was 50.5 \u00b1 8.81 (n = 11) and 56.8 \u00b1 11.06 (n = 6), respectively (p = 0.262). Th e mean pH of arterial blood was 7.34 \u00b1 0.06 (n = 11) and 7.34 \u00b1 0.18 (n = 6) in the positive group and negative group, respectively (p = 0.288).", "cite_spans": [], "ref_spans": [], "section": "Laboratory results"}, {"text": "In 11 patients with S-OIV infection, bacterial cultures of sputum or bronchial aspirate samples were obtained during the hospital stay. Specimens were negative, with the exception of two samples, which were positive for Pseudomonas aeruginosa. Each of the blood specimen cultures taken from 10 patients was negative. Each of the blood specimen cultures, bronchial aspirate samples or bacterial cultures of sputum taken from 11 of 23 patients belonging to the negative group was also negative.", "cite_spans": [], "ref_spans": [], "section": "Laboratory results"}, {"text": "All patients had opacities on a chest radiograph. Bilateral infi ltration was seen more frequently in the patients with S-OIV infection (n = 19, 57.6%) as compared to the negative group (n = 7, 30.4%) (p = 0.044). In 27.3% (n = 9) of the positive group, bilateral expansive infi ltration on upper, medial and lower zones was observed, but there were no patients in whom infi ltration extended throughout the lung zones in the negative group (p = 0.007). Pneumothorax and pleural eff usion were seen in two diff erent patients.", "cite_spans": [], "ref_spans": [], "section": "Radiology"}, {"text": "All of the patients received oseltamivir upon admission, at a dose of 75 mg twice a day. Oseltamavir treatment was maintained for 5 days in the patients with S-OIV infection, but in the negative group, the duration of oseltamivir treatment was limited by the time required to obtain negative laboratory test results for S-OIV. After admission, 17 patients with S-OIV received ceftriaxone and others received ceftriaxone combined with other antibiotics (13 received clarithromycin, 1 received levofl oxacin, 1 received moxifl oxacin). Other initial treatments were imipenem or meropenem for 7 patients (one combined with vancomycin), moxifl oxacin for 2 patients, piperacillin-tazobactam combined with ciprofl oxacin for 2 patients, sulbactam-ampicillin for 2 patients, cefazolin sodium for 2 patients and sulbactam-cefoperazon for 1 patient. Additional antibiotics were prescribed for several patients, on the basis of their clinical course: four were given imipenem or meropenem (combined with vancomycin in two patients); one, piperacillin-tazobactam + vancomycin and one, sulbactamcefoperazon + vancomycin.", "cite_spans": [], "ref_spans": [], "section": "Treatment"}, {"text": "We describe the clinical, radiological and laboratory features of pneumonia that developed in the patients with S-OIV infection. Th e most common symptom was dyspnea. Th e mean peak body temperature during hospital stay amongst patients with S-OIV infection was higher than in the negative group (p = 0.001). Th rombocytopenia, increased creatine kinase and elevated lactate dehydrogenase levels were observed in the patients with S-OIV infection. Bilateral infi ltration was seen more frequently in the patients with S-OIV infection (p = 0.044).", "cite_spans": [], "ref_spans": [], "section": "Discussion"}, {"text": "Swine infl uenza pneumonia was seen in 66% of hospitalised patients with S-OIV infection [7] . Th is number varied in some studies [3, [8] [9] [10] [11] [12] , as did the number of hospitalised patients associated with patient characteristics.", "cite_spans": [{"start": 89, "end": 92, "text": "[7]", "ref_id": "BIBREF6"}, {"start": 131, "end": 134, "text": "[3,", "ref_id": "BIBREF2"}, {"start": 135, "end": 138, "text": "[8]", "ref_id": "BIBREF7"}, {"start": 139, "end": 142, "text": "[9]", "ref_id": "BIBREF8"}, {"start": 143, "end": 147, "text": "[10]", "ref_id": "BIBREF9"}, {"start": 148, "end": 152, "text": "[11]", "ref_id": "BIBREF10"}, {"start": 153, "end": 157, "text": "[12]", "ref_id": "BIBREF11"}], "ref_spans": [], "section": "Discussion"}, {"text": "All of the patients were living in the \u015eanl\u0131urfa province of Turkey and were followed at \u015eanl\u0131urfa Education and Research Hospital, located in the southeastern region of Turkey. Th e mean age of the patients with swine infl uenza pneumonia was lesser than the patients with communityacquired pneumonia. Th e frequency of comorbidity in the patients with swine infl uenza pneumonia was similar to that reported by Perez-Padilla et al. [4] . Most of the studies suggest that some younger and healthy people, especially middle-aged adults and pregnant women, were severely aff ected by S-OIV infection [3] [4] [5] [13] [14] [15] [16] . One study showed that the new H1N1 virus causes pneumonia in ferrets, which is moderate in severity compared to that caused by seasonal H1N1 virus [17] . If we assume that the severity is the same as observed for patients admitted to the ICU in our study, there is no diff erence between healthy and comorbid patients with regard to severity. Extremes in age and multiple and debilitating underlying medical conditions might be contributing to the severity of illness in these patients.", "cite_spans": [{"start": 434, "end": 437, "text": "[4]", "ref_id": "BIBREF3"}, {"start": 599, "end": 602, "text": "[3]", "ref_id": "BIBREF2"}, {"start": 603, "end": 606, "text": "[4]", "ref_id": "BIBREF3"}, {"start": 607, "end": 610, "text": "[5]", "ref_id": "BIBREF4"}, {"start": 611, "end": 615, "text": "[13]", "ref_id": "BIBREF12"}, {"start": 616, "end": 620, "text": "[14]", "ref_id": "BIBREF13"}, {"start": 621, "end": 625, "text": "[15]", "ref_id": "BIBREF14"}, {"start": 626, "end": 630, "text": "[16]", "ref_id": "BIBREF15"}, {"start": 780, "end": 784, "text": "[17]", "ref_id": "BIBREF16"}], "ref_spans": [], "section": "Discussion"}, {"text": "Primary viral pneumonia is the most common fi nding in the patients with severe S-OIV infection [11] . Th e onset of swine infl uenza pneumonia is often abrupt. In adults with S-OIV, pneumonia presents as an infl uenza-like illness with a temperature higher than 39\u00b0C (102\u00b0F) accompanied by prominent myalgia [1] . Th e most consistent symptoms were cough, sore throat, sputum, dyspnea and fever that varied in diff erent studies [4, 13, 18, 19] . In our study, dyspnea and sore throat were most common in swine infl uenza pneumonia.", "cite_spans": [{"start": 96, "end": 100, "text": "[11]", "ref_id": "BIBREF10"}, {"start": 309, "end": 312, "text": "[1]", "ref_id": "BIBREF0"}, {"start": 430, "end": 433, "text": "[4,", "ref_id": "BIBREF3"}, {"start": 434, "end": 437, "text": "13,", "ref_id": "BIBREF12"}, {"start": 438, "end": 441, "text": "18,", "ref_id": "BIBREF17"}, {"start": 442, "end": 445, "text": "19]", "ref_id": "BIBREF18"}], "ref_spans": [], "section": "Discussion"}, {"text": "Th e most consistent laboratory characteristics in our patients with S-OIV infection were thrombocytopenia, increased creatine kinase and elevated lactate dehydrogenase levels. Venkata et al. [20] demonstrated that thrombocytopenia was common in ICU patients. In the reports from Chile [21] and Italy [12] , 20% and 27% of the patients with S-OIV had thrombocytopenia, respectively. More commonly reported in children, myositis associated with infl uenza A and B has been well documented and appears to occur most often during the convalescent phase of illness [22] . Th e elevation of lactate dehydrogenase and creatine kinase levels in swine infl uenza pneumonia is consistent with previous reports of pneumonia associated with S-OIV in Mexico, most likely due to myositis [4] .", "cite_spans": [{"start": 192, "end": 196, "text": "[20]", "ref_id": "BIBREF19"}, {"start": 286, "end": 290, "text": "[21]", "ref_id": "BIBREF20"}, {"start": 301, "end": 305, "text": "[12]", "ref_id": "BIBREF11"}, {"start": 561, "end": 565, "text": "[22]", "ref_id": "BIBREF21"}, {"start": 775, "end": 778, "text": "[4]", "ref_id": "BIBREF3"}], "ref_spans": [], "section": "Discussion"}, {"text": "In our study, the mortality rate of swine infl uenza pneumonia (24.2%) was higher than in the negative group (8.7%), but this fi nding was not statistically signifi cant (p = 0.172). We do not currently know whether our patients had coinfection with other respiratory viruses. During the 1918 pandemic, a large number of deaths were associated with bacterial infection [23] , but concurrent bacterial infection does not appear to be a major contributing factor to the severity of illness in our patients, possibly in part because most received antibiotics during hospitalisation. Delayed admission, delayed initiation of oseltamivir therapy and coinfection with other respiratory viruses could be contributing factors for death in our patients. Higher mortality rates and higher frequency of ARDS and MV as well as lower mean PO2 values in the patients with swine infl uenza pneumonia show that there was a tendency towards severe illness, as compared with community-acquired pneumonia.", "cite_spans": [{"start": 369, "end": 373, "text": "[23]", "ref_id": "BIBREF22"}], "ref_spans": [], "section": "Discussion"}, {"text": "In a study from California, 102 of 227 mechanically ventilated patients with S-OIV infection died [7] . In our study, the small number of mechanically ventilated patients may have skewed the results. In a report from Mexico, most deaths occurred in patients with S-OIV pneumonia who required MV on admission [4] . Another possible cause of high mortality amongst our patients who required MV could be that 8 of 8 patients had transitioned to MV on the fi rst day of admission.", "cite_spans": [{"start": 98, "end": 101, "text": "[7]", "ref_id": "BIBREF6"}, {"start": 308, "end": 311, "text": "[4]", "ref_id": "BIBREF3"}], "ref_spans": [], "section": "Discussion"}, {"text": "Perez-Padilla et al. [4] reported the clinical and ep idemiological features of the fi rst 18 patients with laboratory-confi rmed S-OIV in Mexico. All 18 patients had radio logically confi rmed pneumonia with bilateral patchy alveolar opacities (predominantly basal), aff ecting three or four lung quadrants in 11 patients. Bilateral infi ltrates were seen in 66% (66/100) of the patients in a report from the United States [3] , 94% (64/68) of the patients in a report from China [24] and 59% (10/17) of the patients in a report from Korea [25] . Prachi et al. [26] demonstrated that 71% (20/28) of the patients with S-OIV infection had bilateral Fig. 1 . Axial images from chest computed tomography examination in a patient with swine infl uenza pneumonia. Images show bilateral patchy infiltration on admission day. The patient was discharged from hospital as cured. Bilateral infiltration was seen more frequently in the patients with S-OIV infection (n = 19, 57.6%) than negative group (n = 7, 30.4%) (p = 0.044) involvement on chest radiograph. In this report, 93% of patients that required ICU admission had extensive disease involving \u2265 3 lung zones and all of them had bilateral opacities. Champunot et al. [13] reported that 79.2% (19/24) of the patients had multilobular or bilateral diff use infi ltrate on chest X-ray. Th e report from New Zealand showed that 48% of the patients had multi-lobar infi ltrates [27] . One of the remarkable fi ndings in our study was that 27% of the patients with swine infl uenza pneumonia had infi ltration extending throughout the lung zone, whereas there was not any infi ltration of the entire lung zone in the negative group. Bilateral infi ltration (Fig. 1) was seen more frequently in swine infl uenza pneumonia than in the negative group (p = 0.044). Based on these fi ndings, widespread infi ltrations should alert physicians about distinguishing swine infl uenza pneumonia from community-acquired pneumonia.", "cite_spans": [{"start": 21, "end": 24, "text": "[4]", "ref_id": "BIBREF3"}, {"start": 424, "end": 427, "text": "[3]", "ref_id": "BIBREF2"}, {"start": 481, "end": 485, "text": "[24]", "ref_id": "BIBREF23"}, {"start": 541, "end": 545, "text": "[25]", "ref_id": "BIBREF24"}, {"start": 562, "end": 566, "text": "[26]", "ref_id": "BIBREF25"}, {"start": 1216, "end": 1220, "text": "[13]", "ref_id": "BIBREF12"}, {"start": 1422, "end": 1426, "text": "[27]", "ref_id": "BIBREF26"}], "ref_spans": [{"start": 648, "end": 654, "text": "Fig. 1", "ref_id": null}, {"start": 1700, "end": 1708, "text": "(Fig. 1)", "ref_id": null}], "section": "Discussion"}, {"text": "Our study has several limitations. Firstly, most of the patients were adult (only 3 patients were less than 16 years of age). Secondly, the numbers of patients with and without S-OIV infection were too small to acquire strong statistical data.", "cite_spans": [], "ref_spans": [], "section": "Discussion"}, {"text": "S-OIV pneumonia is a complication of S-OIV infection and can cause serious illness. Although our radiological or clinical data show signifi cant diff erences between the patients with S-OIV pneumonia and the negative group, we suggest that no specifi c constellation seems to be typical of H1N1-associated pneumonia. In conclusion, each patient presenting with signs of pneumonia during pandemia should be tested for Infl uenza A.", "cite_spans": [], "ref_spans": [], "section": "Discussion"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Swine Infl uenza (H1N1) pneumonia: clinical considerations", "authors": [{"first": "B", "middle": ["A"], "last": "Cunha", "suffix": ""}], "year": 2010, "venue": "Infect Dis Clin North Am", "volume": "24", "issn": "", "pages": "203--231", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "World now at the start of 2009 infl uenza pandemic", "authors": [], "year": 2009, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Pandemic Infl uenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 infl uenza in the United States", "authors": [{"first": "S", "middle": [], "last": "Jain", "suffix": ""}, {"first": "L", "middle": [], "last": "Kamimoto", "suffix": ""}, {"first": "A", "middle": ["M"], "last": "Bramley", "suffix": ""}], "year": 2009, "venue": "N Engl J Med", "volume": "361", "issn": "", "pages": "1935--1979", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "Pneumonia and respiratory failure from Swine-Origin Infl uenza A (H1N1) in Mexico", "authors": [{"first": "R", "middle": [], "last": "Perez-Padilla", "suffix": ""}, {"first": "D", "middle": [], "last": "De La Rosa-Zamboni", "suffix": ""}, {"first": "Ponce", "middle": [], "last": "De Leon", "suffix": ""}, {"first": "S", "middle": [], "last": "", "suffix": ""}], "year": 2009, "venue": "N Engl J Med", "volume": "361", "issn": "", "pages": "680--689", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "Severe respiratory disease concurrent with the circulation of H1N1 infl uenza", "authors": [{"first": "G", "middle": [], "last": "Chowell", "suffix": ""}, {"first": "S", "middle": ["M"], "last": "Bertozzi", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Colchero", "suffix": ""}], "year": 2009, "venue": "N Engl J Med", "volume": "361", "issn": "", "pages": "674--683", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "CDC protocol of realtime RTPCR for infl uenza A (H1N1)", "authors": [], "year": 2009, "venue": "", "volume": "6", "issn": "", "pages": "", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Factors associated with death or hospitalization due to pandemic 2009 infl uenza A (H1N1) infection in California", "authors": [{"first": "J", "middle": ["K"], "last": "Louie", "suffix": ""}, {"first": "M", "middle": [], "last": "Acosta", "suffix": ""}, {"first": "K", "middle": [], "last": "Winter", "suffix": ""}], "year": 2009, "venue": "JAMA", "volume": "302", "issn": "", "pages": "1896--902", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "National Infl uenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic infl uenza A (H1N1) virus infection in China", "authors": [{"first": "B", "middle": [], "last": "Cao", "suffix": ""}, {"first": "X", "middle": ["W"], "last": "Li", "suffix": ""}, {"first": "Y", "middle": [], "last": "Mao", "suffix": ""}], "year": 2009, "venue": "N Engl J Med", "volume": "361", "issn": "", "pages": "2507--2524", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "Working Group Pandemic Infl uenza A(H1N1)v. Infl uenza A(H1N1)v in Germany: the first 10,000 cases", "authors": [{"first": "A", "middle": [], "last": "Gilsdorf", "suffix": ""}, {"first": "G", "middle": [], "last": "Poggensee", "suffix": ""}], "year": 2009, "venue": "Euro Surveill", "volume": "14", "issn": "34", "pages": "", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "Impact of the novel Infl uenza A (H1N1) during the 2009 Autumn-Winter season in a large hospital setting in", "authors": [{"first": "J", "middle": ["P"], "last": "Torres", "suffix": ""}, {"first": "M", "middle": [], "last": "O&apos;ryan", "suffix": ""}, {"first": "B", "middle": [], "last": "Herve", "suffix": ""}], "year": 2010, "venue": "Clin Infect Dis", "volume": "50", "issn": "", "pages": "860--868", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "Centers for Disease Negative and Prevention. Hospitalized patients with novel infl uenza A (H1N1) virus infection -California", "authors": [], "year": 2009, "venue": "Morb Mortal Wkly Rep", "volume": "58", "issn": "", "pages": "536--577", "other_ids": {}}, "BIBREF11": {"ref_id": "b11", "title": "Risk factors for severe complications of the novel infl uenza A (H1N1): analysis of patients hospitalized in Italy", "authors": [{"first": "M", "middle": [], "last": "Bassetti", "suffix": ""}, {"first": "A", "middle": [], "last": "Parisini", "suffix": ""}, {"first": "A", "middle": [], "last": "Calzi", "suffix": ""}], "year": 2010, "venue": "Clin Microbiol Infect", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1111/j.1469-0691.2010.03275.x"]}}, "BIBREF12": {"ref_id": "b12", "title": "Impact of Pandemic Infl uenza (H1N1) Virus-Associated Community-Acquired Pneumonia among Adults in a Tertiary Hospital in Th ailand", "authors": [{"first": "R", "middle": [], "last": "Champunot", "suffix": ""}, {"first": "S", "middle": [], "last": "Tanjatham", "suffix": ""}, {"first": "A", "middle": [], "last": "Kerdsin", "suffix": ""}], "year": 2010, "venue": "Jpn J Infect Dis", "volume": "63", "issn": "", "pages": "251--257", "other_ids": {}}, "BIBREF13": {"ref_id": "b13", "title": "Th e severity of pandemic H1N1 infl uenza in the United States", "authors": [{"first": "A", "middle": ["M"], "last": "Presanis", "suffix": ""}, {"first": "D ;", "middle": [], "last": "De Angelis", "suffix": ""}, {"first": "A", "middle": [], "last": "Hagy", "suffix": ""}], "year": 2009, "venue": "New York City Swine Flu Investigation Team", "volume": "6", "issn": "", "pages": "", "other_ids": {}}, "BIBREF14": {"ref_id": "b14", "title": "Progression and impact of the first winter wave of the 2009 pandemic H1N1 infl uenza in New South Wales, Australia", "authors": [], "year": 2009, "venue": "Euro Surveill", "volume": "14", "issn": "42", "pages": "", "other_ids": {}}, "BIBREF15": {"ref_id": "b15", "title": "Th e first wave of pandemic infl uenza (H1N1) 2009 in Germany: From initiation to accelaration", "authors": [{"first": "G", "middle": [], "last": "Poggensee", "suffix": ""}, {"first": "A", "middle": [], "last": "Gilsdorf", "suffix": ""}, {"first": "S", "middle": [], "last": "Buda", "suffix": ""}], "year": 2010, "venue": "BMC Infect Dis", "volume": "10", "issn": "", "pages": "", "other_ids": {}}, "BIBREF16": {"ref_id": "b16", "title": "Severity of pneumonia due to new H1N1 infl uenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian infl uenza H5N1 virus", "authors": [{"first": "J", "middle": ["M"], "last": "Van Den Brand", "suffix": ""}, {"first": "K", "middle": ["J"], "last": "Stittelaar", "suffix": ""}, {"first": "G", "middle": [], "last": "Van Amerongen", "suffix": ""}], "year": 2010, "venue": "J Infect Dis", "volume": "201", "issn": "", "pages": "993--1002", "other_ids": {}}, "BIBREF17": {"ref_id": "b17", "title": "Critical analysis of deaths due to atypical pneumonia during the onset of the infl uenza A (H1N1) virus epidemic", "authors": [{"first": "I", "middle": [], "last": "Grijalva-Otero", "suffix": ""}, {"first": "J", "middle": ["O"], "last": "Talavera", "suffix": ""}, {"first": "F", "middle": [], "last": "Solorzano-Santos", "suffix": ""}], "year": 2009, "venue": "Arch Med Res", "volume": "40", "issn": "", "pages": "662--670", "other_ids": {}}, "BIBREF18": {"ref_id": "b18", "title": "Dynamics of clinical symptoms in patients with pandemic infl uenza A (H1N1)", "authors": [{"first": "C", "middle": ["S"], "last": "Lee", "suffix": ""}, {"first": "J", "middle": ["H"], "last": "Lee", "suffix": ""}], "year": 2010, "venue": "Clin Microbiol Infect", "volume": "16", "issn": "", "pages": "389--90", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "Hospitalized patients with 2009 H1N1 infl uenza infection: Th e Mayo Clinic Experience", "authors": [{"first": "C", "middle": [], "last": "Venkata", "suffix": ""}, {"first": "P", "middle": [], "last": "Sampathkumar", "suffix": ""}, {"first": "B", "middle": [], "last": "Afessa", "suffix": ""}], "year": 2010, "venue": "Mayo Clin Proc", "volume": "85", "issn": "", "pages": "798--805", "other_ids": {}}, "BIBREF20": {"ref_id": "b20", "title": "Infl uenza A pandemics: clinical and organizational aspects: the experience in Chile", "authors": [{"first": "S", "middle": [], "last": "Ugarte", "suffix": ""}, {"first": "F", "middle": [], "last": "Arancibia", "suffix": ""}, {"first": "R", "middle": [], "last": "Soto", "suffix": ""}], "year": 2010, "venue": "Crit Care Med", "volume": "38", "issn": "", "pages": "133--140", "other_ids": {}}, "BIBREF21": {"ref_id": "b21", "title": "Infl uenzaassociated myositis in children", "authors": [{"first": "P", "middle": [], "last": "Agyeman", "suffix": ""}, {"first": "A", "middle": [], "last": "Duppenthaler", "suffix": ""}, {"first": "U", "middle": [], "last": "Heininger", "suffix": ""}], "year": 2004, "venue": "Infection", "volume": "32", "issn": "", "pages": "199--203", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "Predominant role of bacterial pneumonia as a cause of death in pandemic infl uenza: implications for pandemic infl uenza preparedness", "authors": [{"first": "D", "middle": ["M"], "last": "Morens", "suffix": ""}, {"first": "J", "middle": ["K"], "last": "Taubenberger", "suffix": ""}, {"first": "A", "middle": ["S"], "last": "Fauci", "suffix": ""}], "year": 2008, "venue": "J Infect Dis", "volume": "198", "issn": "", "pages": "962--70", "other_ids": {}}, "BIBREF23": {"ref_id": "b23", "title": "Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 infl uenza in Shenyang, China", "authors": [{"first": "W", "middle": [], "last": "Cui", "suffix": ""}, {"first": "H", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "X", "middle": [], "last": "Lu", "suffix": ""}], "year": 2010, "venue": "BMC Infect Dis", "volume": "10", "issn": "", "pages": "", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "Clinical characteristics of pneumonia in hospitalized patiets with novel infl uenza A (H1N1) in Korea", "authors": [{"first": "W", "middle": ["J"], "last": "Choi", "suffix": ""}, {"first": "W", "middle": ["Y"], "last": "Kim", "suffix": ""}, {"first": "S", "middle": ["H"], "last": "Kim", "suffix": ""}], "year": 2010, "venue": "Scand J Infect Dis", "volume": "42", "issn": "", "pages": "311--315", "other_ids": {}}, "BIBREF25": {"ref_id": "b25", "title": "Chest radiographic and CT findings in novel swine-origin infl uenza A (H1N1) virus (S-OIV) infection", "authors": [{"first": "P", "middle": ["P"], "last": "Agarwal", "suffix": ""}, {"first": "S", "middle": [], "last": "Cinti", "suffix": ""}, {"first": "E", "middle": ["A"], "last": "Kazerooni", "suffix": ""}], "year": 2009, "venue": "Am J Roentgenol", "volume": "193", "issn": "", "pages": "1488--93", "other_ids": {}}, "BIBREF26": {"ref_id": "b26", "title": "Clinical and epidemiological characteristics of the hospitalised patients due to pandemic H1N1 2009 viral infection: experience at Hutt Hospital", "authors": [{"first": "S", "middle": [], "last": "Dee", "suffix": ""}, {"first": "S", "middle": [], "last": "Jayathissa", "suffix": ""}], "year": 2010, "venue": "N Z Med J", "volume": "123", "issn": "", "pages": "45--53", "other_ids": {}}}, "ref_entries": {"TABREF0": {"text": "Characteristics of the patients with pneumonia who had S-OIV infection", "latex": null, "type": "table"}, "TABREF1": {"text": "Comparison of the symptoms during admission in the positive group and negative groups", "latex": null, "type": "table"}, "TABREF2": {"text": "Frequency of MV, ARDS and exitus in both groups", "latex": null, "type": "table"}, "TABREF3": {"text": "Laboratory findings of the patients with S-OIV infection and negative group*", "latex": null, "type": "table"}, "TABREF4": {"text": "Table 1. Th e minimum and maximum Table 1.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td> Characteristics of the patients with pneumonia who had S-OIV infection\n</td></tr><tr><td>Variable </td><td>Value\n</td></tr><tr><td>Gender - no (%) Male\n</td><td>20 (60.6)\n</td></tr><tr><td>Female\nAge - year\n</td><td>13 (39.4)\n</td></tr><tr><td>Median\n</td><td>30\n</td></tr><tr><td>Range\n</td><td>13-70\n</td></tr><tr><td>Occupation - no (%) Housewife\n</td><td>12 (36.4)\n</td></tr><tr><td>Unemployed Freelancer\n</td><td>8 (24.2) 5 (15.2)\n</td></tr><tr><td>Farmer\n</td><td>4 (12.1)\n</td></tr><tr><td>Comorbidities - no (%)* </td><td>14 (42.42)\n</td></tr><tr><td>Hospital stay - in days\n</td><td>\u00a0</td></tr><tr><td>Mean\n</td><td>6.42 \u00b1 4.56\n</td></tr><tr><td>Range\nICU stay - in days\n</td><td>1-24\n</td></tr><tr><td>Mean\n</td><td>6.0 \u00b1 6.0\n</td></tr><tr><td>Range\n</td><td>1-24\n</td></tr><tr><td>Duration of symptoms onset to admission - in days Mean\n</td><td>4.3 \u00b1 2.31\n</td></tr><tr><td>Range\n</td><td>2-10\n</td></tr><tr><td>\u00a0</td><td>*The number of patients who had at least one comorbidity.\n</td></tr></table></body></html>"}, "TABREF5": {"text": "Table 3). Neither patients in the positive group with ARDS nor those who underwent MV survived. Laboratory results\nA complete blood cell count was performed on all 33 patients and on the negative group. Th e results of the blood Table 4.", "latex": null, "type": "table", "html": "<html><body><table><tr><td> Laboratory findings of the patients with S-OIV infection and negative group*\nVariable </td><td>Positive group </td><td>Negative group </td><td>p**\n</td></tr><tr><td>Hemoglobin\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean value in patients with anemia\n</td><td>10.96 \u00b1 1.0\n</td><td>10.12 \u00b1 1.49\n</td><td>\u00a0</td></tr><tr><td>Anemia - no (%)\n</td><td>11 (33.3) </td><td>6 (26.1) </td><td>0.562\n</td></tr><tr><td>Leucocyte count Mean count in patients with leucocytosis - cells/mm3\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Leucocytosis - no (%)\n</td><td>19,458 \u00b1 14,132 12 (36.4)\n</td><td>17,433 \u00b1 7,484\n12 (52.2) </td><td>0.240\n</td></tr><tr><td>Lymphocyte count\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean count in patients with lymphopenia - cells/mm3\nLymphopenia - no (%)\n</td><td>600.0 \u00b1 209.8 11 (33.3)\n</td><td>600.0 \u00b1 238.1\n7 (30.4) </td><td>0.819\n</td></tr><tr><td>Platelet count\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean count in patients with thrombocytopenia - cells/mm3\n</td><td>108,285 \u00b1 31,555\n</td><td>131,500 \u00b1 20,506\n</td><td>\u00a0</td></tr><tr><td>Thrombocytopenia - no (%)\n</td><td>14 (42.4)\n</td><td>2 (8.7) </td><td>0.007\n</td></tr><tr><td>Alanine aminotransferase (ALT)\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean value in patients with elevated ALT - U/l\n</td><td>99.4 \u00b1 71.56\n</td><td>99.24 \u00b1 29.90\n</td><td>\u00a0</td></tr><tr><td>Elevated ALT - no (%)\n</td><td>5 (15.6)\n</td><td>7 (30.4) </td><td>0.190\n</td></tr><tr><td>Aspartate aminotransferase (AST) Mean value in patients with elevated AST - U/l Elevated AST - no (%)\n</td><td>72.68 \u00b1 52.37 16 (50)\n</td><td>90.69 \u00b1 58.72\n11 (47.8) </td><td>0.874\n</td></tr><tr><td>Gamma-glutamyl transpeptidase (GGT)\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean value in patients with elevated GGT - U/l Elevated GGT - no (%)\n</td><td>124.89 \u00b1 61.27 9 (31)\n</td><td>113.49 \u00b1 71.48\n6 (27.3) </td><td>0.770\n</td></tr><tr><td>Lactate dehydrogenase (LDH)\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean value in patients with elevated LDH - U/l Elevated LDH - no (%)\n</td><td>649.68 \u00b1 421.47 28 (90.3)\n</td><td>680.0 \u00b1 325.97\n13 (61.9) </td><td>0.019\n</td></tr><tr><td>Creatine kinase (CK) Mean value in patients with elevated CK - U/l\n</td><td>516.47 \u00b1 409.84\n</td><td>586.28 \u00b1 527.75\n</td><td>\u00a0</td></tr><tr><td>Elevated CK - no (%)\n</td><td>15 (60)\n</td><td>5 (23.8) </td><td>0.014\n</td></tr><tr><td>Serum creatinin Mean value in patients with elevated serum creatinin - mg/dl\n</td><td>1.77 \u00b1 0.32\n</td><td>-\n</td><td>\u00a0</td></tr><tr><td>Elevated serum creatinin - no (%)\n</td><td>2 (6.3)\n</td><td>0 (0) </td><td>0.504\n</td></tr><tr><td>Blood urea\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean value in patients with elevated blood urea - mg/dl Elevated blood urea - no (%)\n</td><td>68.88 \u00b1 13.45 5 (15.6)\n</td><td>69.33 \u00b1 11.72\n3 (13.0) </td><td>1\n</td></tr><tr><td>C-reactive protein (CRP)\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Mean value in patients with positive CRP - mg/l Positive CRP - no (%)\n</td><td>17.65 \u00b1 10.43 13 (61.9)\n</td><td>18.18 \u00b1 10.72\n8 (50) </td><td>0.469\n</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>*Plus-minus values are means \u00b1 SD; **Pearson chi-squared test and Fisher's exact test were performed.\n</td></tr></table></body></html>"}}, "back_matter": [{"text": "We are indebted to Dr. Ay\u015fe G\u00f6lc\u00fck, Dr. Melis Bozda\u011f, Dr. Ay\u015feg\u00fcl Acar, Dr. Re\u015fat Ye\u015filo\u011flu, Dr. T\u00fclay Keskin and Infection Control Team, \u015eanl\u0131urfa Education and Research Hospital, for their valuable technical and logistical support.", "cite_spans": [], "ref_spans": [], "section": "Acknowledgements"}, {"text": "No fi nancial or other potential confl icts of interest exist.", "cite_spans": [], "ref_spans": [], "section": "Confl ict of interest"}, {"text": "Pneumonia in patients with novel infl uenza A (H1N1) virus wkw 3-4/2011 \u00a9 Springer-Verlag", "cite_spans": [], "ref_spans": [], "section": "original article"}]}